Pamela DeLuca

790 total citations
10 papers, 574 citations indexed

About

Pamela DeLuca is a scholar working on Oncology, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Pamela DeLuca has authored 10 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Nutrition and Dietetics. Recurrent topics in Pamela DeLuca's work include Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Fatty Acid Research and Health (2 papers). Pamela DeLuca is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Fatty Acid Research and Health (2 papers). Pamela DeLuca collaborates with scholars based in United States, Netherlands and Switzerland. Pamela DeLuca's co-authors include Robert B. Zurier, Patricia LoRusso, Shirish M. Gadgeel, Román Herrera, Judith S. Sebolt–Leopold, Mary Varterasian, Alex A. Adjei, Jill Piens, Mark B. Meyer and Lorelei J. Hanson and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Leukocyte Biology.

In The Last Decade

Pamela DeLuca

10 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela DeLuca United States 8 354 210 91 67 60 10 574
Karthika Natarajan United States 12 396 1.1× 416 2.0× 114 1.3× 59 0.9× 36 0.6× 32 793
Fengyun Dong China 17 235 0.7× 130 0.6× 42 0.5× 61 0.9× 129 2.1× 25 612
Chung‐Wai Shiau Taiwan 15 256 0.7× 182 0.9× 99 1.1× 41 0.6× 81 1.4× 33 598
Valérie Le Morvan France 18 389 1.1× 310 1.5× 77 0.8× 30 0.4× 34 0.6× 45 745
Andrew DeCastro United States 11 249 0.7× 156 0.7× 52 0.6× 31 0.5× 22 0.4× 15 472
Mark Wade United States 13 314 0.9× 150 0.7× 54 0.6× 24 0.4× 98 1.6× 35 632
Youqiu Xue China 13 331 0.9× 173 0.8× 60 0.7× 22 0.3× 202 3.4× 18 734
Michiko Maeyama Japan 9 370 1.0× 172 0.8× 82 0.9× 40 0.6× 63 1.1× 12 1.0k
Hiroyasu Imanishi Japan 16 183 0.5× 67 0.3× 31 0.3× 85 1.3× 72 1.2× 44 734

Countries citing papers authored by Pamela DeLuca

Since Specialization
Citations

This map shows the geographic impact of Pamela DeLuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela DeLuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela DeLuca more than expected).

Fields of papers citing papers by Pamela DeLuca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela DeLuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela DeLuca. The network helps show where Pamela DeLuca may publish in the future.

Co-authorship network of co-authors of Pamela DeLuca

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela DeLuca. A scholar is included among the top collaborators of Pamela DeLuca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela DeLuca. Pamela DeLuca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
LoRusso, Patricia, Shirish M. Gadgeel, Antoinette Wozniak, et al.. (2008). Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors. Investigational New Drugs. 26(2). 159–167. 54 indexed citations
2.
Bröker, Linda E., Mary Jo Pilat, Pamela DeLuca, et al.. (2008). Effect of Food on the Pharmacokinetic Behavior of the Potent Oral Taxane BMS-275183. Clinical Cancer Research. 14(13). 4186–4191. 5 indexed citations
3.
Shields, Anthony F., Elisabeth I. Heath, Pamela DeLuca, et al.. (2007). AZD2171 in combination with various anticancer regimens: Follow-up results of a phase I multi-cohort study. Journal of Clinical Oncology. 25(18_suppl). 3544–3544. 7 indexed citations
4.
Alousi, Amin M., Ramesh Boinpally, Richard Wiegand, et al.. (2006). A phase 1 trial of XK469: Toxicity profile of a selective topoisomerase IIβ inhibitor. Investigational New Drugs. 25(2). 147–154. 23 indexed citations
5.
LoRusso, Patricia, Alex A. Adjei, Mary Varterasian, et al.. (2005). Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies. Journal of Clinical Oncology. 23(23). 5281–5293. 316 indexed citations
6.
Eder, Joseph P., Rocio García‐Carbonero, Jeffrey W. Clark, et al.. (2004). A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies. Investigational New Drugs. 22(2). 139–150. 29 indexed citations
7.
DeLuca, Pamela, et al.. (1999). Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo.. PubMed. 47(5). 246–50. 42 indexed citations
8.
Rossetti, Ronald G., et al.. (1997). Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation. Journal of Leukocyte Biology. 62(4). 438–443. 53 indexed citations
9.
DeLuca, Pamela, Deborah Rothman, & Robert B. Zurier. (1995). MARINE AND BOTANICAL LIPIDS AS IMMUNOMODULATORY AND THERAPEUTIC AGENTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS. Rheumatic Disease Clinics of North America. 21(3). 759–777. 31 indexed citations
10.
Rothman, Deborah, Pamela DeLuca, & Robert B. Zurier. (1995). Botanical lipids: Effects on inflammation, immune responses, and rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 25(2). 87–96. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026